Results 61 to 70 of about 21,517 (267)
Potential entry pathways for 25 vector‐borne disease agents
Abstract This Scientific Report identifies the potential entry pathways for 25 selected vector‐borne diseases (VBDs) into currently free EU Member States. The diseases comprise 12 listed under the Animal Health Law (AHL) and 13 non‐listed diseases, selected using predefined eligibility criteria.
European Food Safety Authority (EFSA) +7 more
wiley +1 more source
Knowledge mapping of risk mitigation measures against vector‐borne diseases
Abstract A comprehensive synthesis of current evidence on surveillance, prevention and control measures for 25 selected vector‐borne diseases (VBDs) affecting animals in the EU is presented here. The assessment integrates evidence from systematic literature reviews, modelling studies, field investigations and expert judgement.
European Food Safety Authority (EFSA) +8 more
wiley +1 more source
Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein
The Rift Valley fever virus (RVFV) is an arthropod-borne virus that can not only cause severe disease in domestic animals but also in humans. However, the licensed vaccines or available therapeutics for humans do not exist.
Meng Hao +13 more
doaj +1 more source
Natural hosts and animal models for Rift Valley fever phlebovirus
Rift Valley fever phlebovirus (RVFV) is a zoonotic mosquito-transmitted arbovirus, presenting a serious threat to humans and animals. Susceptible hosts are of great significance for the prevention of RVFV.
Yuqing Xu +15 more
doaj +1 more source
A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep [PDF]
Citation: Faburay, B., Wilson, W. C., Gaudreault, N. N., Davis, A. S., Shivanna, V., Bawa, B., . . . Richt, J. A. (2016). A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in ...
Bawa, Bhupinder +11 more
core +1 more source
Abstract This report addresses Term of Reference 1.2 by providing a comprehensive knowledge‐mapping of arthropod vector species competent to transmit selected vector‐borne diseases (VBDs) including VBDs listed under Regulation (EU) 2016/429 and Regulation (EU) 2020/687, as well as additional non‐listed pathogens with potential epidemiological relevance.
European Food Safety Authority (EFSA) +7 more
wiley +1 more source
A variant of Rift Valley fever virus.
Click on the link to view.
Weinbren, MP, Williams, MC, Haddow, AJ
openaire +2 more sources
Vector‐borne diseases‐knowledge maps
Abstract This scientific report provides a structured overview of the main characteristics of 25 selected vector‐borne diseases (VBDs) of potential relevance for the EU, including 12 diseases listed under the Animal Health Law (AHL) and 13 non‐listed diseases.
European Food Safety Authority (EFSA) +7 more
wiley +1 more source
Enzootic Activity of Rift Valley Fever Virus in Senegal
In two areas of Senegal where previous evidence of Rift Valley fever (RVF) virus circulation was detected, Barkedji in the Sahelian bioclimatic zone and Kedougou in the Sudano-Guinean zone, a longitudinal study of the enzootic maintenance of RVF virus was undertaken from 1991 to 1993.
Zeller, H.G. +4 more
openaire +3 more sources
Advances in Understanding Neuropathogenesis of Rift Valley Fever Virus
Rift Valley fever virus (RVFV) is an emerging arboviral pathogen that causes disease in both livestock and humans. Severe disease manifestations of Rift Valley fever (RVF) in humans include hemorrhagic fever, ocular disease, and encephalitis. This review describes the current understanding of the pathogenesis of RVF encephalitis.
Connors, Kaleigh A., Hartman, Amy L.
openaire +2 more sources

